Transvenous pacing leads: increased risk of systemic thromboemboli in patients with intracardiac shunts
Mitchell I Cohen
Correspondence Arizona Pediatric Cardiology Consultants, Phoenix Children's Hospital, 1920 East Cambridge Street, Phoenix, AZ 85006, USA
Email mitchell_cohen@pediatrix.com
This article has no abstract so we have provided the first paragraph of the full text.
As pediatric cardiologists caring for an increasing patient population surviving congenital heart surgery, we are often confronted with patients requiring a pacemaker or ICD. The decision of whether to implant a pacemaker or ICD via an endocardial or epicardial route is based on a multitude of factors including patient age and size, and whether residual cardiac lesions are present. Inherent in these considerations is the potential that thrombus formation, even on a well-positioned endocardial lead, could result in a paradoxical systemic thromboembolus if there is a residual shunt.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
